IL1B and colitis: They also confirmed the inhibitory effect of DMI on DSS-induced colitis, and this protective effect was attributed to the inhibited secretion of IL-1β and CCL2 by intestinal epithelial cells and the inhibited recruitment of macrophages and myeloid-derived suppressor cells [18].